Optimising the accuracy of blood pressure monitoring in chronic kidney disease: The utility of BpTRU

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Brothwell, Shona ^b   Dutton, Mary ^a   Ferro, Charles ^a,b   Stringer, Stephanie ^a,b   Cockwell, Paul ^a,b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; SPHYGMOMANOMETER; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE DETERMINATION; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; FEMALE; HUMANS; HYPERTENSION, RENAL; MALE; MIDDLE AGED; MONITORING, AMBULATORY; RENAL INSUFFICIENCY, CHRONIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84885145936     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-218     Document Type: Article

References (78)

1. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS, Am J Kidney Dis 2003 41 1 12 12500213 (Pubitemid 36043346)
2. A collaborative meta-analysis of general and high-risk population cohorts. Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, the Chronic Kidney Disease Prognosis Consortium: Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes, Kidney Int 2011 80 93 104 10.1038/ki.2010.531 21289597
3. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt K-U, Kidney Int 2011 80 17 28 10.1038/ki.2010.483 21150873
4. A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure. Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, Levin A, Levey AS, JAMA 2011 305 15 1553 1559 10.1001/jama.2011.451 21482743
5. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Coresh J, Wei GL, McQuillan G, Brancati FL, Levey AS, Jones C, Klag MJ, Arch Intern Med 2001 161 1207 1216 10.1001/archinte.161.9.1207 11343443 (Pubitemid 32691517)
6. Hypertension awareness, treatment, and control in chronic kidney disease. Sarafidis PA, Li S, Chen SC, Collins AJ, Brown WW, Klag MJ, Bakris GL, Am J Med 2008 121 332 340 10.1016/j.amjmed.2007.11.025 18374693 (Pubitemid 351444786)
7. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G, N Engl J Med 1994 330 877 884 10.1056/NEJM199403313301301 8114857 (Pubitemid 24094966)
8. Progression of diabetic nephropathy in normotensive type 1 diabetic patients. Jacobsen P, Rossing K, Tarnow L, Rossing P, Mallet C, Poirier O, Cambien F, Parving HH, Kidney Int 1999 56 Suppl 71 101 105
9. Importance of blood pressure control in chronic kidney disease. Ravera M, Re M, Deferrari L, Vettoretti S, Deferrari G, J Am Soc Nephrol 2006 17 Suppl 2 98 103
10. National Institute for Health and Clinical Excellence (NICE) clinical guideline 73, Chronic kidney disease: Early identification and management of chronic kidney disease in adults in primary and secondary care 2008
11. Does this patient have hypertension? How to measure blood pressure. Reeves RA, JAMA 1995 273 1211 1218 10.1001/jama.1995.03520390071036 7707630
12. The effect of alternative criteria for hypertension on estimates of prevalence and control. Birkett NJ, J Hypertens 1997 15 237 244 10.1097/00004872-199715030-00004 9468450 (Pubitemid 27129112)
13. Evidence based treatment of hypertension. Measurement of blood pressure: an evidence based review. McAlister FA, Straus SE, BMJ 2001 322 7291 908 911 10.1136/bmj.322.7291.908 11302909 (Pubitemid 32324318)
14. Blood pressure measurement and detection of hypertension. Pickering TG, Lancet 1994 344 8914 31 35 10.1016/S0140-6736(94)91053-7 7912303 (Pubitemid 24199424)
15. Prognostic importance of clinic and home blood pressure recordings in patients with chronic kidney disease. Agarwal R, Anderson MJ, Kidney Int 2006 69 406 411 10.1038/sj.ki.5000081 16408134 (Pubitemid 43323095)
16. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement: a randomized controlled trial. Staessen JA, Byttebier G, Buntinx F, Celis H, O'Brien ET, Fagard R, JAMA 1997 278 1065 1072 10.1001/jama.1997.03550130039034 9315764 (Pubitemid 27418332)
17. Masked hypertension. Pickering TG, Davidson K, Gerin W, Schwartz JE, Hypertension 2002 40 795 796 10.1161/01.HYP.0000038733.08436.98 12468559 (Pubitemid 35434896)
18. Is ambulatory blood pressure monitoring cost-effective in the routine surveillance of treated hypertensive patients in primary care? Lorgelly P, Siatis I, Brooks A, Slinn B, Millar-Craig MW, Donnelly R, Manning G, Br J Gen Pract 2003 53 495 794 796 14601356 (Pubitemid 37254125)
19. Home blood pressure monitoring in CKD. Andersen MJ, Khawandi W, Agarwal R, Am J Kidney Dis 2005 45 994 1001 10.1053/j.ajkd.2005.02.015 15957127 (Pubitemid 40806511)
20. Masked hypertension and white-coat hypertension in chronic kidney disease: a meta-analysis. Bangash F, Agarwal R, Clin J Am Soc Nephrol 2009 4 3 656 664 10.2215/CJN.05391008 19261815
21. The unsupported arm: a cause of falsely raised blood pressure readings. Silverberg DS, Shemesh E, Iaina A, BMJ 1977 2 1331 (Pubitemid 8233328)
22. Spurious hypertension in the obese patient. Effect of sphygmomanometer cuff size on prevalence of hypertension. Linfors EW, Feussner JR, Blessing CL, Starmer CF, Neelon FA, McKee PA, Arch Intern Med 1984 144 1482 1485 10.1001/archinte.1984.00350190188032 6732409 (Pubitemid 14087083)
23. Effect of back support and stethoscope head position on seated blood pressure determinations. Cushman WC, Cooper KM, Horne RA, Meydrech EF, Am J Hypertens 1990 3 240 241 2322436 (Pubitemid 20166167)
24. Effects of cuff inflation on self-recorded blood pressure. Veerman DP, Van Montfrans GA, Wieling W, Lancet 1990 335 451 453 10.1016/0140-6736(90)90676- V 1968178 (Pubitemid 20054659)
25. Clinical decision-making in hypertension using an automated (BpTRU) measurement device. Graves JW, Nash C, Burger K, Bailey K, Sheps SG, J Hum Hypertens 2003 17 12 823 827 10.1038/sj.jhh.1001626 14704726 (Pubitemid 38028639)
26. Validation of new algorithm for the BPM-100 electronic oscillometric office blood pressure monitor. Wright JM, Mattu GS, Perry TL Jr, Gelfer ME, Strange KD, Zorn A, Chen Y, Blood Press Monit 2001 6 161 165 10.1097/00126097-200106000-00008 11518840 (Pubitemid 32744590)
27. Evaluation of the overall efficacy of the Omron office digital blood pressure HEM-907 monitor in adults. White WG, Anwar YA, Blood Press Monit 2001 6 107 110 10.1097/00126097-200104000-00007 11433132 (Pubitemid 32587668)
28. Validation of Microlife Watch BP Office Professional device for office blood pressure measurement according to the international protocol. Stergiou GS, Tzamouranis D, Protogerou A, Nasothimiou E, Kapralos C, Blood Press Monit 2008 13 299 303 10.1097/MBP.0b013e3283057af6 18799957
29. The BpTRU automatic blood pressure monitor compared to 24-h ambulatory blood pressure monitoring in the assessment of blood pressure in patients with hypertension. Beckett L, Godwin M, BMC Cardiovasc Disord 2005 5 18 10.1186/1471-2261-5-18 15985180 (Pubitemid 41460660)
30. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lovibond K, Jowett S, Barton P, Caulfield M, Heneghan C, Hobbs FDR, Hodgkinson J, Mant J, Martin U, Williams B, Wonderling D, McManus RJ, Lancet 2011 378 1219 1230 10.1016/S0140-6736(11)61184-7 21868086
31. Correlates of systolic hypertension in patients with chronic kidney disease. Agarwal R, Andersen MJ, Hypertension 2005 46 514 520 10.1161/01.HYP.0000178102.85718.66 16103271 (Pubitemid 41376831)
32. Out-of-office blood pressure monitoring in chronic kidney disease. Agarwal R, Peixoto AJ, Santos SFF, Zoccali C, Blood Press Monit 2009 14 2 11 10.1097/MBP.0b013e3283262f58 19194283
33. Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate. Davidson MB, Hix JK, Vidt DG, Brotman DJ, Arch Intern Med 2006 166 846 852 10.1001/archinte.166.8.846 16636209
34. African American study of kidney disease and hypertension collaborative research group: disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Pogue V, Rahman M, Lipkowitz M, Toto R, Miller E, Faulkner M, Rostand S, Hiremath L, Sika M, Kendrick C, Hu B, Greene T, Appel L, Phillips RA, Hypertension 2009 53 20 27 10.1161/HYPERTENSIONAHA.108.115154 19047584
35. Comparison of Ambulatory Blood Pressure Parameters of Hypertensive Patients With and Without Chronic Kidney Disease. Mojón A, Ayala DE, Piñeiro L, Otero A, Crespo JJ, Moyá A, Bóveda J, Pérez de Lis J, Fernández JR, Hermida RC, Chronobiol Int 2013 30 1-2 145 158 23181690
36. Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. Hermida RC, Ayala DE, Mojón A, Fernández JR, J Am Soc Nephrol 2011 22 2313 2321 10.1681/ASN.2011040361 22025630
37. Non-dipping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in haemodialysis patients. Liu M, Takahashi H, Morita Y, Nephrol Dial Transplant 2003 18 563 569 10.1093/ndt/18.3.563 12584280 (Pubitemid 36305663)
38. Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Minutolo R, Agarwal R, Borrelli S, Chiodini P, Bellizzi V, Nappi F, Cianciaruso B, Zamboni P, Conte G, Gabbai FB, De Nicola L, Arch Intern Med 2011 171 1090 1098 10.1001/archinternmed.2011.230 21709109
39. Prognostic value of 24-hour ambulatory blood pressure monitoring and of night/day ratio in nondiabetic, cardiovascular events-free hemodialysis patients. Tripepi G, Fagugli RM, Dattolo P, Parlongo G, Mallamaci F, Buoncristiani U, Zoccali C, Kidney Int 2005 68 1294 1302 10.1111/j.1523-1755. 2005.00527.x 16105064 (Pubitemid 43246450)
40. Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease. Crespo JJ, Piñeiro L, Otero A, Castiñeira C, Ríos MT, Regueiro A, Mojón A, Lorenzo S, Ayala DE, Hermida RC, Chronobiol Int 2013 30 1-2 159 175 23098134
41. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund- Bodegård K, Richart T, Ohkubo T, Kuznetsova T, Torp-Pedersen CH, Lind L, Ibsen H, Imai Y, Wang J, Sandoya E, O'Brien E, Staessen JA, Lancet 2007 370 1219 1229 10.1016/S0140-6736(07)61538-4 17920917 (Pubitemid 47503300)
42. Impaired diurnal blood pressure variation and all-cause mortality. Brotman DJ, Davidson MB, Boumitri M, Vidt DG, Am J Hypertens 2008 21 92 97 10.1038/ajh.2007.7 18091750
43. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O'Brien E, Hypertension 2005 46 156 161 10.1161/01.HYP.0000170138.56903.7a 15939805 (Pubitemid 40946507)
44. Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes. Eguchi K, Pickering TG, Hoshide S, Ishikawa J, Ishikawa S, Schwartz J, Shimada K, Kario K, Am J Hypertens 2008 21 443 450 10.1038/ajh.2008.4 18292756 (Pubitemid 351450870)
45. Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes. Hermida RC, Ayala DE, Mojón A, Fernández JR, Am J Hypertens 2012 25 325 334 10.1038/ajh.2011.231 22158066
46. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Hermida RC, Ayala DE, Fernández JR, Mojón A, Chronobiol Int 2013 30 68 86 10.3109/07420528.2012.702581 23181592
47. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level-the "normotensive nondipper" paradox. Hermida RC, Ayala DE, Mojón A, Fernández JR, Chronobiol Int 2013 30 87 98 10.3109/07420528.2012.701127 23039824
48. Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal events in NIDDM subjects. Nakano S, Fukuda M, Hotta F, Ito T, Ishii T, Kitazawa M, Nishizawa M, Kigoshi T, Uchida K, Diabetes 1998 47 1501 1506 10.2337/diabetes.47.9.1501 9726241 (Pubitemid 28396956)
49. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S, Imai Y, J Hypertens 2002 20 2183 2189 10.1097/00004872-200211000-00017 12409956 (Pubitemid 35388236)
50. Non-dipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus. Sturrock ND, George E, Pound N, Stevenson J, Peck GM, Sowter H, Diabet Med 2000 17 360 364 10.1046/j.1464-5491. 2000.00284.x 10872534 (Pubitemid 30353800)
51. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistell M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G, Hypertension 1994 24 793 801 10.1161/01.HYP.24.6.793 7995639 (Pubitemid 24363980)
52. Comparison of acceptability and preferences for different methods of measuring blood pressure in primary care. Little P, Barnett J, Barnsley L, Marjoram J, Fitzgerald-Barron A, Mant D, BMJ 2002 325 258 259 10.1136/bmj.325.7358.258 12153924 (Pubitemid 34864394)
53. Can sphygmomanometers designed for self-measurement of blood pressure in the home be used in office practice? Myers MG, Valdivieso M, Chessman M, Kiss A, Blood Press Monit 2010 15 6 300 304 10.1097/MBP.0b013e328340d128 20975533
54. Manual and automated office measurements in relation to awake ambulatory blood pressure monitoring. Godwin M, Birtwhistle R, Delva D, Lam M, Casson I, MacDonald S, Seguin R, Fam Pract 2011 28 110 117 10.1093/fampra/cmq067 20720213
55. Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: randomised parallel design controlled trial. Myers MG, Godwin M, Dawes M, Kiss A, Tobe SW, Grant FC, Kaczorowski J, BMJ 2011 342 286 10.1136/bmj.d286 21300709
56. In-office assessment of blood pressure in chronic kidney disease: usual measurement versus automated BpTRU measurement. O'Shaughnessy MM, Newman CA, Kinsella SM, Reddan DN, Lappin DW, Blood Press Monit 2011 16 3 124 128 10.1097/MBP.0b013e328346e0db 21562454
57. Comparison of Dinamap Pro-100 and mercury sphygmomanometer blood pressure measurements in a population based study. Ni K, Wu C, Prineas R, Shea S, Liu K, Kronmal R, Bild D, Am J Hypertension 2006 19 353 360 10.1016/j.amjhyper.2005. 10.020
58. Optimum frequency of office blood pressure measurement using an automated sphygmomanometer. Myers MG, Valdivieso M, Kiss A, Blood Press Monit 2008 13 6 333 338 10.1097/MBP.0b013e3283104247 19020423
59. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P, the European Society of Hypertension Working Group on Blood Pressure Monitoring, J Hypertension 2003 21 821 848 10.1097/00004872-200305000-00001 (Pubitemid 36677141)
60. Comparison between an automated and manual sphygmomanometer in a population survey. Myers MG, McInnis NH, Fodor GJ, Leenen FH, Am J Hypertens 2008 21 3 280 283 10.1038/ajh.2007.54 18219304 (Pubitemid 351323269)
61. Automated blood pressure measurement in routine clinical practice. Myers MG, Blood Press Monit 2006 11 59 62 10.1097/01.mbp.0000200481.64787.c0 16534406 (Pubitemid 44090017)
62. Chronotherapy of hypertension. Hermida RC, Smolensky MH, Curr Opin Nephrol Hypertens 2004 13 501 505 10.1097/00041552-200409000-00004 15300155 (Pubitemid 39150075)
63. Administration time-dependent effects of antihypertensive treatment on the circadian pattern of blood pressure. Hermida RC, Ayala DE, Calvo C, Curr Opin Nephrol Hypertens 2005 14 453 459 10.1097/01.mnh.0000174144.07174.74 16046904 (Pubitemid 41152708)
64. Chronotherapy of hypertension: administration-time dependent effects of treatment on the circadian pattern of blood pressure. Hermida RC, Ayala DE, Calvo C, Portaluppi F, Smolensky MH, Adv Drug Deliv Rev 2007 59 923 939 10.1016/j.addr.2006.09.021 17659803 (Pubitemid 47531897)
65. Chronotherapy with valsartan/amlodipine combination in essential hypertension: improved blood pressure control with bedtime dosing. Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández JR, Chronobiol Int 2010 27 1287 1303 10.3109/07420528.2010.489167 20653455
66. Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications. Hermida RC, Ayala DE, Fernández JR, Portaluppi F, Fabbian F, Smolensky MH, Am J Hypertens 2011 24 383 391 10.1038/ajh.2010.217 20930708
67. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing. Hermida RC, Ayala DE, Mojón A, Fontao MJ, Fernández JR, Chronobiol Int 2011 28 601 610 10.3109/07420528.2011.589935 21823969
68. Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation. Hermida RC, Ayala DE, Fernández JR, Mojón A, Smolensky MH, Fabbian F, Portaluppi F, Chronobiol Int 2013 30 280 314 10.3109/07420528.2012.709448 23077971
69. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications. Hermida RC, Ayala DE, Mojón A, Fernández JR, Chronobiol Int 2013 30 315 327 10.3109/07420528.2012.701534 23181712
70. Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study. Portaluppi F, Smolensky MH, Chronobiol Int 2010 27 1652 1667 10.3109/07420528.2010.510788 20854140
71. Administration-time-dependent effect of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F, Blood Press Monit 2010 15 173 180 10.1097/MBP.0b013e32833c7308 20571367
72. Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications. Ayala DE, Hermida RC, Mojón A, Fernández JR, Chronobiol Int 2013 30 340 352 10.3109/07420528.2012.701455 23077973
73. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Hermida RC, Ayala DE, Mojón A, Fernández JR, Chronobiol Int 2010 27 1629 1651 10.3109/07420528.2010. 510230 20854139
74. Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. Hermida RC, Ayala DE, Mojón A, Fernández JR, J Am Coll Cardiol 2011 58 1165 1173 10.1016/j.jacc.2011.04. 043 21884956
75. Influence of time of day of blood pressure lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Hermida RC, Ayala DE, Mojón A, Fernández JR, Diabetes Care 2011 34 1270 1276 10.2337/dc11-0297 21617110
76. Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension- associated risk, and attainment of therapeutic goals. Hermida RC, Smolensky MH, Ayala DE, Portaluppi F, Crespo JJ, Fabbian F, Haus E, Manfredini R, Mojón A, Moyá A, Piñeiro L, Ríos MT, Otero A, Balan H, Fernández JR, Chronobiology Int 2013 30 3 355 410 10.3109/07420528.2013. 7504902013
77. ESH/ ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), Eur Heart J 2013 10.1093/eurheartj/eht1512013
78. National Institute for Health and Clinical Excellence (NICE) clinical guideline 127, Clinical management of primary hypertension in adults 2011